Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

Altered levels of cerebrospinal fluid (CSF) peptides related to Alzheimer’s disease (AD) are associated with pathologic AD diagnosis, although cognitively normal subjects can also have abnormal levels of these AD biomarkers. To identify novel CSF biomarkers that distinguish pathologically confirmed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hu, William T., Chen-Plotkin, Alice, Arnold, Steven E., Grossman, Murray, Clark, Christopher M., Shaw, Leslie M., Pickering, Eve, Kuhn, Max, Chen, Yu, McCluskey, Leo, Elman, Lauren, Karlawish, Jason, Hurtig, Howard I., Siderowf, Andrew, Lee, Virginia M.-Y., Soares, Holly, Trojanowski, John Q.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2880811/
https://ncbi.nlm.nih.gov/pubmed/20232070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-010-0667-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars